Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
Clinical trial NCT03250338 · COMPLETED
Trial details
- NCT number
- NCT03250338
- Sponsor
- Arog Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2026-04-03
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.